References
- United Nations Department of Economic and Social Affairs Population Division. World contraceptive use 2007. Accessed 5 August 2009 from: http://www.un.org/esa/population/publications/contraceptive2007/contraceptive_2007_table.pdf
- Rosenberg MJ, Meyers A, Roy V. Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: A randomized trial of 20 micrograms and 35 micrograms estrogen preparations. Contraception 1999;60:321–9.
- Blackburn RD, Cunkelman JA, Zlidar VM. Oral contraceptives – an update. Baltimore: Johns Hopkins University School of Public Health, Population Information Program; Spring 2000.
- Farley TM, Collins J, Schlesselman JJ. Hormonal contraception and risk of cardiovascular disease. An international perspective. Contraception 1998;57:211–30.
- Hoffmann H, Moore C, Zimmermann H, et al Approaches to the replacement of ethinylestradiol by natural 17 beta-estradiol in combined oral contraceptives. Exp Toxicol Pathol 1998;50:458–64.
- Calaf i Alsina J. After 50 years of ethinylestradiol, another oestrogen in combined oral contraceptives. Eur J Contracept Reprod Health Care 2010;15:1–3.
- Hirvonen E, Allonen H, Anttila M, et al Oral contraceptive containing natural estradiol for premenopausal women. Maturitas 1995;21:27–32.
- Koetsawang S, Mandlekar AV, Krishna UR, et al A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens. World Health Organization Task Force on Oral Contraception. Contraception 1980;21:445–59.
- Wenzl R, Coelingh Bennink H, van Beek A, et al Ovulation inhibition with a combined oral contraceptive containing 1 mg micronized 17 beta-estradiol. Fertil Steril 1993;60:616–9.
- Sitruk-Ware R. New progestagens for contraceptive use. Hum Reprod Update 2006;12:169–78.
- Kuhl H. Pharmacology of estrogens and progestogens: Influence of different routes of administration. Climacteric 2005;8(Suppl. 1):3–63.
- Catherino WH, Jordan VC. Nomegestrol acetate, a clinically useful 19-norprogesterone derivative which lacks estrogenic activity. J Steroid Biochem Mol Biol 1995;55:239–46.
- Ezan E, Benech H, Bucourt R, et al Enzyme immunoassay for nomegestrol acetate in human plasma. J Steroid Biochem Mol Biol 1993;46:507–14.
- Couzinet B, Young J, Kujas M, et al The antigonadotropic activity of a 19-nor-progesterone derivative is exerted both at the hypothalamic and pituitary levels in women. J Clin Endocrinol Metab 1999;84:4191–6.
- Bazin B, Thevenot R, Bursaux C, et al Effect of nomegestrol acetate, a new 19-nor-progesterone derivative, on pituitary-ovarian function in women. Br J Obstet Gynaecol 1987;94:1199–204.
- Barbosa IC, Maia H, Jr, Coutinho E, et al Effects of a single Silastic contraceptive implant containing nomegestrol acetate (Uniplant) on endometrial morphology and ovarian function for 1 year. Contraception 2006;74:492–7.
- Basdevant A, Pelissier C, Conard J, et al Effects of nomegestrol acetate (5 mg/d) on hormonal, metabolic and hemostatic parameters in premenopausal women. Contraception 1991;44:599–605.
- Dorangeon P, Thomas JL, Choisy H, et al Effects of nomegestrol acetate on carbohydrate metabolism. Diabetes Metab 1993;19:441–5.
- Insler V, Melmed H, Eichenbrenner I, et al The cervical score. A simple semiquantitative method for monitoring the menstrual cycle. Int J Gynaecol Obstet 1972;10:223–8.
- Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666–72.
- Landgren BM, Diczfalusy E. Hormonal effects of the 300 microgram norethisterone (NET) minipill. I. Daily steroid levels in 43 subjects during a pretreatment cycle and during the second month of NET administration. Contraception 1980;21:87–113.
- Milsom I, Korver T. Ovulation incidence with oral contraceptives: A literature review. J Fam Plann Reprod Health Care 2008;34:237–46.
- Serfaty D, Christin Maitre S, Ochsenbein E, et al Comparison of two regimens of new monophasic oral contraceptive combining 17 beta-estradiol and nomegestrol acetate. Poster (Abstract 738.P) presented at XIX FIGO World Congress of Gynecology and Obstetrics, Cape Town, South Africa, 4–9 October 2009.
- Korver T, Goorissen E, Guillebaud J. The combined oral contraceptive pill: What advice should we give when tablets are missed? Br J Obstet Gynaecol 1995;102:601–7.
- Mashchak CA, Lobo RA, Dozono-Takano R, et al Comparison of pharmacodynamic properties of various estrogen formulations. Am J Obstet Gynecol 1982;144:511–8.
- Schindler AE, Campagnoli C, Druckmann R, et al Classification and pharmacology of progestins. Maturitas 2003;46(Suppl. 1):S7–S16.